Impact of Racial Differences in Alzheimer Biomarkers
What underlies the higher prevalence of Alzheimer disease among older African Americans?
Women Face Greater Challenges With Alzheimer Disease Than Men
A look at sex differences in the neuropsychological deficits of Alzheimer disease.
A Game Plan for Prevention of Antidepressant Adverse Effects
Recommendations from an international panel of experts on the management of MDD.
MDD: Closing in on the Right Drug at the Right Dose
Here: an alternative to the trial-and-error method that can boost treatment response rates.
Good Vibes About Early Diagnosis of Alzheimer Disease
Blood-based vibrational spectroscopy shows promise as a screening tool for dementia.
Crazy Work Hours Do Not Drive Dementia
A look at the impact of shift work and long hours on cognitive function.
Curb Your Enthusiasm for ACE Inhibitors in Alzheimer Disease
Recent findings challenge the notion that these agents can provide sustained protection against cognitive decline.
Updated Key to the Diagnosis of Dementia
Alzheimer disease—or dementia with Lewy bodies? Recently revised consensus criteria can help you solve this diagnostic dilemma.
Key to Prevention of Cognitive Decline in Hypertensive Patients
Although high blood pressure may put patients at risk for dementia, a class of antihypertensives appears to have a preventive effect.
Alzheimer Prevention: The Skinny on Genes and Fats
The genetics of dementia, dyslipidemia, and diabetes may hold the key to preventive therapy.
By clicking Accept, you agree to become a member of the UBM Medica Community.